Argent Biopharma Ltd has released a press release.
Appendix 4E and 2026 Annual Report
Earlier from Argent Biopharma
- FDA-CVM Establish INAD File for CannEpil Veterinary Program
- US Veterinary Development Programme for CannEpil Commences
- CannEpil Global Licence Expands into Veterinary Healthcare
- RGT Executes Global CannEpil Licensing Deal for US$5.5M